Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.
Autor: | Simsek, Eda Tanrikulu, Eskazan, Ahmet Emre, Cengiz, Mahir, Cem Ar, Muhlis, Ekizoglu, Seda, Salihoglu, Ayse, Gulturk, Emine, Elverdi, Tugrul, Aydin, Seniz Ongoren, Demiroz, Ahu Senem, Buyru, Ayse Nur, Baslar, Zafer, Ozbek, Ugur, Ferhanoglu, Burhan, Aydin, Yildiz, Tuzuner, Nukhet, Soysal, Teoman |
---|---|
Předmět: | |
Zdroj: | Journal of Clinical Pathology; Sep2016, Vol. 69 Issue 9, p810-816, 7p, 1 Color Photograph, 5 Charts, 2 Graphs |
Databáze: | Complementary Index |
Externí odkaz: |